Company intelligence / Profile preview

Life Sciences Angel Network

Ownership: Private
Development stage: Other

Overview

Life Sciences Angel Network is an angel investment group providing operational support, mentorship, financial backing and professional networks to early-stage life science startups. It has made at least four known investments since inception and had one notable exit with Yaro being acquired in 2020. The organization focuses on supporting innovation across biotechnology and healthcare by investing at seed or early venture rounds.

Modalities: Small moleculeBiologicMedical deviceDigital health solutions
Industry: Investors

Partnerships

7wire VenturesAzimuth VenturesDallas Venture PartnersLightbankMartin VenturesZaffre Investments

Beyond the preview

Go deeper on Life Sciences Angel Network.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Life Sciences Angel Network.

Explore the full profile